Cargando…
RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer
The p90 ribosomal S6 kinase (RSK) is a family of MAPK-activated serine/threonine kinases (RSK1-4) whose expression and/or activity are deregulated in several cancers, including breast cancer. Up-regulation of RSKs promotes cellular processes that drive tumorigenesis in Triple Negative Breast Cancer...
Autores principales: | Cuesta, Rafael, Holz, Marina K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053672/ https://www.ncbi.nlm.nih.gov/pubmed/27028868 http://dx.doi.org/10.18632/oncotarget.8375 |
Ejemplares similares
-
Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT
por: Jin, Yujin, et al.
Publicado: (2019) -
Down-Regulation of PDCD4 Promotes Proliferation, Angiogenesis and Tumorigenesis in Glioma Cells
por: Pin, Guo, et al.
Publicado: (2020) -
Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells
por: Fernandez-Gallardo, Miriam, et al.
Publicado: (2016) -
MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018) -
Identifying requirements for RSK2 specific inhibitors
por: Wright, Eric B., et al.
Publicado: (2021)